Clinton, N.J., July 15 /PRNewswire/ -- Ikaria, Inc. today announced that Martin Meglasson, Ph.D., will join Ikaria as Chief Science Officer. Dr. Meglasson will be responsible for activities related to early-stage drug development.

CLINTON, N.J., July 8 /PRNewswire/ -- Ikaria, Inc. today announced that Craig Tooman will join Ikaria as Senior Vice President and Chief Financial Officer (CFO). In this role, Mr. Tooman will be responsible for all financial functions of the company, as well as for information technology services.

ST. LOUIS, Nov. 9, 2009 /PRNewswire-FirstCall/ -- Monsanto Company (NYSE: MON) and Pfizer Inc (NYSE: PFE) today announced that they have entered into an agreement for Monsanto to acquire Pfizer's Chesterfield Village Research Center located in Chesterfield, Mo.

BOSTON, Oct. 16 /PRNewswire-USNewswire/ -- PHARMACIA & UPJOHN COMPANY, INC., a subsidiary of Pfizer Inc. ("Pfizer") today was sentenced today in federal court for a felony violation of the Food, Drug & Cosmetic Act, for misbranding the drug, Bextra, with the intent to defraud or mislead.

Pfizer to Pay $2.3 Billion for Fraudulent Marketing WASHINGTON, Sept. 2 /PRNewswire-USNewswire/ -- American pharmaceutical giant Pfizer Inc. and its subsidiary Pharmacia & Upjohn Company Inc.